SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026067
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:56
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_tffpharma.htm 10-Q 278462
2 CERTIFICATION f10q0321ex31-1_tffpharma.htm EX-31.1 11674
3 CERTIFICATION f10q0321ex31-2_tffpharma.htm EX-31.2 11414
4 CERTIFICATION f10q0321ex32-1_tffpharma.htm EX-32.1 5235
5 GRAPHIC image_001.jpg GRAPHIC 11475
  Complete submission text file 0001213900-21-026067.txt   1861896

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE tffp-20210331.xml EX-101.INS 191274
7 XBRL SCHEMA FILE tffp-20210331.xsd EX-101.SCH 34192
8 XBRL CALCULATION FILE tffp-20210331_cal.xml EX-101.CAL 18203
9 XBRL DEFINITION FILE tffp-20210331_def.xml EX-101.DEF 117915
10 XBRL LABEL FILE tffp-20210331_lab.xml EX-101.LAB 254132
11 XBRL PRESENTATION FILE tffp-20210331_pre.xml EX-101.PRE 128185
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39102 | Film No.: 21919618
SIC: 2834 Pharmaceutical Preparations